532 related articles for article (PubMed ID: 28228317)
1. Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.
Elkind-Hirsch KE; Paterson MS; Seidemann EL; Gutowski HC
Fertil Steril; 2017 Jan; 107(1):253-260.e1. PubMed ID: 28228317
[TBL] [Abstract][Full Text] [Related]
2. Effects of saxagliptin added to sub-maximal doses of metformin compared with uptitration of metformin in type 2 diabetes: the PROMPT study.
Hermans MP; Delibasi T; Farmer I; Lohm L; Maheux P; Piatti P; Malvolti E; Jörgens S; Charbonnel B
Curr Med Res Opin; 2012 Oct; 28(10):1635-45. PubMed ID: 23020253
[TBL] [Abstract][Full Text] [Related]
3. Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin.
Rosenstock J; Hansen L; Zee P; Li Y; Cook W; Hirshberg B; Iqbal N
Diabetes Care; 2015 Mar; 38(3):376-83. PubMed ID: 25352655
[TBL] [Abstract][Full Text] [Related]
4. Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy.
Barnett AH; Charbonnel B; Li J; Donovan M; Fleming D; Iqbal N
Clin Drug Investig; 2013 Oct; 33(10):707-17. PubMed ID: 23949898
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult subjects.
Boulton DW; Smith CH; Li L; Huang J; Tang A; LaCreta FP
Clin Drug Investig; 2011; 31(9):619-30. PubMed ID: 21819160
[TBL] [Abstract][Full Text] [Related]
6. Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin.
Barnett AH; Charbonnel B; Donovan M; Fleming D; Chen R
Curr Med Res Opin; 2012 Apr; 28(4):513-23. PubMed ID: 22313154
[TBL] [Abstract][Full Text] [Related]
7. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
8. Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.
Tao T; Wu P; Wang Y; Liu W
BMC Endocr Disord; 2018 Feb; 18(1):14. PubMed ID: 29482528
[TBL] [Abstract][Full Text] [Related]
9. SHORT-TERM SITAGLIPTIN-METFORMIN THERAPY IS MORE EFFECTIVE THAN METFORMIN OR PLACEBO IN PRIOR GESTATIONAL DIABETIC WOMEN WITH IMPAIRED GLUCOSE REGULATION.
Elkind-Hirsch KE; Paterson MS; Shaler D; Gutowski HC
Endocr Pract; 2018 Apr; 24(4):361-368. PubMed ID: 29561188
[TBL] [Abstract][Full Text] [Related]
10. Saxagliptin and metformin XR combination therapy provides glycemic control over 24 hours in patients with T2DM inadequately controlled with metformin.
Stenlöf K; Raz I; Neutel J; Ravichandran S; Berglind N; Chen R
Curr Med Res Opin; 2010 Oct; 26(10):2355-63. PubMed ID: 20804445
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of saxagliptin vs glimepiride as a second-line therapy added to metformin in Type 2 diabetes in China.
Gu S; Deng J; Shi L; Mu Y; Dong H
J Med Econ; 2015; 18(10):808-20. PubMed ID: 25950193
[TBL] [Abstract][Full Text] [Related]
12. Adding saxagliptin to extended-release metformin vs. uptitrating metformin dosage.
Fonseca V; Zhu T; Karyekar C; Hirshberg B
Diabetes Obes Metab; 2012 Apr; 14(4):365-71. PubMed ID: 22192246
[TBL] [Abstract][Full Text] [Related]
13. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
[TBL] [Abstract][Full Text] [Related]
14. The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial.
Dore FJ; Domingues CC; Ahmadi N; Kundu N; Kropotova Y; Houston S; Rouphael C; Mammadova A; Witkin L; Khiyami A; Amdur RL; Sen S
Cardiovasc Diabetol; 2018 May; 17(1):65. PubMed ID: 29724198
[TBL] [Abstract][Full Text] [Related]
15. Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study.
Tao T; Zhang Y; Zhu YC; Fu JR; Wang YY; Cai J; Ma JY; Xu Y; Gao YN; Sun Y; Fan W; Liu W
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1420-e1432. PubMed ID: 32995892
[TBL] [Abstract][Full Text] [Related]
16. Saxagliptin + metformin. Mostly disadvantages.
Prescrire Int; 2013 Feb; 22(135):40. PubMed ID: 23444500
[No Abstract] [Full Text] [Related]
17. Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin.
Qin Y; Adams J; Solis-Herrera C; Triplitt C; DeFronzo R; Cersosimo E
Diabetes Care; 2020 Oct; 43(10):2519-2527. PubMed ID: 32694214
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial.
Vilsbøll T; Ekholm E; Johnsson E; Dronamraju N; Jabbour S; Lind M
Diabetes Care; 2019 Aug; 42(8):1464-1472. PubMed ID: 31167892
[TBL] [Abstract][Full Text] [Related]
19. Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial.
Li J; Ng EH; Stener-Victorin E; Hu Z; Shao X; Wang H; Li M; Lai M; Xie C; Su N; Yu C; Liu J; Wu T; Ma H
Trials; 2017 Mar; 18(1):115. PubMed ID: 28274268
[TBL] [Abstract][Full Text] [Related]
20. Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.
Göke B; Gallwitz B; Eriksson J; Hellqvist A; Gause-Nilsson I;
Int J Clin Pract; 2010 Nov; 64(12):1619-31. PubMed ID: 20846286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
